In a number of reports decreased epithelial Sdc1 expression was associated with an advanced clinical stage of colon tumors or poor prognosis [29,30], while one study associated epithelial Sdc1 immunopositivity with increased tumor size in colorectal carcinoma [32]. Here, SDC1 is linked to colonic neoplasm.